N5334 Module 4
3 types of information needed for neuropharmacologic drugs: - ANS - Type of receptors through
which the drug acts.
Normal response to the activation of those receptors (agonist vs. antagonist).
What the drug in question does to receptor function.
\A ________ inotrope will increase contractility; a ________ chronotrope will decrease heart
rate, while a ________ dromotrope will decrease conduction via the AV node. - ANS - Positive
Negative
Negative
\A 32 year old male is starting Paroxetine for depression. He is complaining of not being able to
obtain an erection. What can the NP do to help. - ANS - Add Bupropion
\A 55 y/o patient develops Parkinson's disease characterized by unilateral tremors only. The NP
will refer the patient to a neurologist and should expect initial treatment to be: - ANS - Ropinirole
\A 6 year old is being treated with ethosuximide. She should be monitored for: - ANS - Blood
dyscrasias which are uncommon but possible
\Acetylcholine binds to both __________ and __________ receptors - ANS - Nicotinic
Muscarinic
\Adrenergic receptor - ANS - epinephrine and norepinephrine
\Alpha I agonists ______ blood pressure while alpha I antagonists ________ blood pressure. -
ANS - Increase
Decrease
\Alpha II agonist such as clonidine will ________ BP? - ANS - Lower
\An anticholinergic drug will ________ acetylcholine availability to the tissue. - ANS - Decrease
\Asthma inhaler - ANS - Albuterol
\Atropine is considered to be the antidote to __________ toxicity. - ANS - Cholinergic
\Beta I receptor activation will ________ heart rate.
Beta I blockade will ________ heart rate. - ANS - Increase
Decrease
\Beta II receptor activation will lead to ________ however, administering a non-cardioselective
betablocker can lead to ________. - ANS - Bronchodilation
Bronchoconstriction
\Bradycardia, urinary urgency, bronchoconstriction, and pupillary constriction are signs of -
toxicity. - ANS - Cholinergic
3 types of information needed for neuropharmacologic drugs: - ANS - Type of receptors through
which the drug acts.
Normal response to the activation of those receptors (agonist vs. antagonist).
What the drug in question does to receptor function.
\A ________ inotrope will increase contractility; a ________ chronotrope will decrease heart
rate, while a ________ dromotrope will decrease conduction via the AV node. - ANS - Positive
Negative
Negative
\A 32 year old male is starting Paroxetine for depression. He is complaining of not being able to
obtain an erection. What can the NP do to help. - ANS - Add Bupropion
\A 55 y/o patient develops Parkinson's disease characterized by unilateral tremors only. The NP
will refer the patient to a neurologist and should expect initial treatment to be: - ANS - Ropinirole
\A 6 year old is being treated with ethosuximide. She should be monitored for: - ANS - Blood
dyscrasias which are uncommon but possible
\Acetylcholine binds to both __________ and __________ receptors - ANS - Nicotinic
Muscarinic
\Adrenergic receptor - ANS - epinephrine and norepinephrine
\Alpha I agonists ______ blood pressure while alpha I antagonists ________ blood pressure. -
ANS - Increase
Decrease
\Alpha II agonist such as clonidine will ________ BP? - ANS - Lower
\An anticholinergic drug will ________ acetylcholine availability to the tissue. - ANS - Decrease
\Asthma inhaler - ANS - Albuterol
\Atropine is considered to be the antidote to __________ toxicity. - ANS - Cholinergic
\Beta I receptor activation will ________ heart rate.
Beta I blockade will ________ heart rate. - ANS - Increase
Decrease
\Beta II receptor activation will lead to ________ however, administering a non-cardioselective
betablocker can lead to ________. - ANS - Bronchodilation
Bronchoconstriction
\Bradycardia, urinary urgency, bronchoconstriction, and pupillary constriction are signs of -
toxicity. - ANS - Cholinergic
